Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Alfasigma, Apozeal, Beam, Bio Palette, Eli Lilly, GSK, Medicus, Merck, Rapport, Springworks, Tenacia, Tevogen, Venturemed.

Clinical updates for biopharma and med tech, including data readouts and publications: Aisa, Helus, Neuspera, Roche, Tonix, Zealand.

Biopharma and med-tech companies raising money in public or private financings, including: Calidi, Minnesota, Rakovina, Shuttle, Solid.

The top 10 biopharma stock gainers and losers for the week.

New hires and promotions in the biopharma and med-tech industries, including: Cellbox, Hutchmed, Inimmune, Orexo, Salus, Tersis, Valcare, Vdyne.

These graphs compare the performance of the biotech stocks for all of 2026 using the BioWorld Stock Indicator and the Nasdaq Biotech Index.

Year-to-date money raised in public, private and other financings of biopharma companies.

Total raised in public, private and other financings of biopharma companies, comparing 2019-2026.

Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Airiver, Becton Dickinson, Biomerica, Drug Farm, Hansa, Hemab, Pepgen, Perimeter.

Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Bcworld, Carisma, Charles River, Daiichi Sankyo, Gaia, Grünenthal, Flo, Immunis, Imperial, Liberate, Nano-x, Novigenix, Oxipit, Sectra, Therna, Toray.